These observations were validated by IHC in a cohort of 251 clinical ESCC cases, where elevated NUDT21 and LDHA levels correlated with reduced FDX1 expression and unfavorable prognosis (Fig. 6c, d; Supplementary Fig. S10e). The gene discussed is LDHA; the disease is esophageal squamous cell carcinoma.